Ulkenia sp. – Marine Microorganism and DHA Source

What is Ulkenia sp.?

Ulkenia sp. refers to a genus of marine, single-celled microorganisms belonging to the group of thraustochytrids (order Thraustochytrida). Although they resemble microalgae in appearance, thraustochytrids are phylogenetically classified within the Stramenopiles, making them more closely related to brown algae and water moulds than to true algae or fungi. Ulkenia species occur naturally in marine sediments, mangrove forests, and coastal waters.

Importance as a DHA Source

Ulkenia sp. is primarily cultivated and commercially used for its high content of docosahexaenoic acid (DHA), a long-chain, polyunsaturated omega-3 fatty acid that is essential for the development and function of the brain, eyes, and cardiovascular system. Unlike conventional fish oil production, the cultivation of Ulkenia sp. enables a sustainable, fish-free DHA production process.

Mechanism of Action and Biosynthesis

Ulkenia sp. synthesises DHA via a specialised polyketide synthase-like (PKS-like) metabolic pathway, which differs from classical fatty acid synthesis. This pathway enables efficient and direct production of DHA without the stepwise elongation and desaturation of fatty acid chains typical of other organisms. The fatty acids are stored in lipid droplets within the cell and can be extracted at scale through fermentation processes.

Medical and Nutritional Applications

DHA derived from Ulkenia sp. is used in several areas:

• Infant formula: DHA supplementation to support brain and visual development in newborns and infants.
• Dietary supplements: Vegan and vegetarian omega-3 preparations as an alternative to fish oil.
• Functional foods: Enrichment of dairy products, baked goods, and other foods with DHA.
• Medical nutrition: Use in patients with elevated cardiovascular risk or neurological conditions.

Regulatory Status and Safety

DHA-rich oil derived from Ulkenia sp. has been assessed as safe for consumption by the European Food Safety Authority (EFSA) and the US Food and Drug Administration (FDA), receiving Generally Recognized as Safe (GRAS) status. Studies confirm good tolerability and bioavailability of DHA from Ulkenia sources comparable to that from fish oil.

Sustainability Aspects

The fermentative production of DHA from Ulkenia sp. offers significant ecological advantages over the fish oil industry. It reduces pressure on marine ecosystems, avoids the accumulation of contaminants such as heavy metals and PCBs that can be present in fish oil, and allows for controlled, reproducible production under standardised conditions.

References

1. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA): Safety of DHA-rich oil from Ulkenia sp. as a novel food ingredient. EFSA Journal, 2014;12(10):3840.
2. Barclay W, Weaver C, Metz J: Development of a docosahexaenoic acid production technology using Schizochytrium and related genera. In: Omega-3 Fatty Acids: Chemistry, Nutrition, and Health Effects. ACS Symposium Series, 2003.
3. Ryckebosch E, Bruneel C, Muylaert K, Foubert I: Microalgae as an alternative source of omega-3 long chain polyunsaturated fatty acids. Lipid Technology, 2012;24(6):128-130.